To create awareness and enable knowledge-sharing around Venous diseases, in order to drive better patient care, BD (Becton, Dickinson, and Company) conducted roadshows across New Delhi, Mumbai and Bangalore recently. Venous disease is a condition where the veins in the body have difficulty returning blood to the heart, thereby resulting in blood clot forming in a vein, typically in the legs. If left untreated, these clots can break loose and travel to the lungs, causing serious complications. Delayed detection and intervention can lead to worsened clinical outcomes and a multitude of problems for both patients and healthcare professionals.
Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Aurangabad manufacturing facility. The inspection was conducted from March 6 to March 15, 2024. The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI).
Syngene International Limited has reported Consolidated financial results for the period ended March 31, 2024.
Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance. Orchid Pharma, which is seeing a turnaround under its new promoter Dhanuka Group, aspires to be a fully integrated powerhouse of cephalosporin antibiotics, the company's top executive said
Nestle India profit beats estimates on strong demand; forms JV with Dr. Reddy's
The government has broadened the committee which will look into the reforms in pricing for drugs and medical devices so as to have better representation from the industry.
Pharmaceutical industry and trade leaders in Telangana have offered full support to the state drugs control administration (DCA) for its stringent actions against illegal and unethical business practices continuing in pharma and health sectors.
Indian pharma companies need to explore various pricing strategies to ensure optimum returns while coming up with generic drugs to utilise the patent cliff opportunities where over 20 drugs with sales worth $251 billion are going off-patent in the current decade, according to a study by the Department of Pharmaceuticals (DoP).
A Transcatheter Aortic Valve Replacement (TAVR) was successfully conducted in a morbidly obese patient with critical aortic stenosis conducted at Lilavati Hospital in Mumbai. The 73 -year-old male morbidly obese patient (class III obesity) with BMI of 44 from Dubai, with history of type 2 diabetes mellitus, hypertension and depression complained of dyspnoea on exertion and had great difficulty in walking even a few steps without being breathless.
In the wake of the issue of quality of drugs, it is high time for the Union health ministry to conduct a nationwide survey to substantiate the quality of biological drugs and blood products which are moving in the Indian market, according to a retired CDSCO officer who was at the National Institute of Biologicals (NIB) in Noida for more than four years as quality control officer.